Technical Analysis for PCSA - Processa Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.80 | 2.27% | 0.04 |
PCSA closed up 2.27 percent on Friday, May 24, 2024, on 1 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 2.27% | |
| Down 3 Days in a Row | Weakness | 2.27% | |
| Down 4 Days in a Row | Weakness | 2.27% | |
| Down 5 Days in a Row | Weakness | 2.27% |
| Alert | Time |
|---|---|
| Up 3% | 4 days ago |
| Up 2% | 4 days ago |
| Up 1% | 4 days ago |
| Fell Below Lower Bollinger Band | 5 days ago |
| Fell Below Previous Day's Low | 5 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its product pipeline is PCS499, which is use for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.
Sector: Healthcare
Industry: Biotechnology
Keywords: Drug Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Drug Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.0 |
| 52 Week Low | 1.4 |
| Average Volume | 1,803,960 |
| 200-Day Moving Average | 5.37 |
| 50-Day Moving Average | 2.10 |
| 20-Day Moving Average | 2.10 |
| 10-Day Moving Average | 1.96 |
| Average True Range | 0.19 |
| RSI (14) | 40.83 |
| ADX | 15.5 |
| +DI | 21.98 |
| -DI | 26.33 |
| Chandelier Exit (Long, 3 ATRs) | 2.11 |
| Chandelier Exit (Short, 3 ATRs) | 2.31 |
| Upper Bollinger Bands | 2.50 |
| Lower Bollinger Band | 1.70 |
| Percent B (%b) | 0.12 |
| BandWidth | 37.99 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0403 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.91 | ||||
| Resistance 3 (R3) | 1.90 | 1.87 | 1.89 | ||
| Resistance 2 (R2) | 1.87 | 1.84 | 1.87 | 1.88 | |
| Resistance 1 (R1) | 1.83 | 1.82 | 1.85 | 1.84 | 1.88 |
| Pivot Point | 1.80 | 1.80 | 1.81 | 1.80 | 1.80 |
| Support 1 (S1) | 1.76 | 1.77 | 1.78 | 1.77 | 1.72 |
| Support 2 (S2) | 1.73 | 1.75 | 1.73 | 1.72 | |
| Support 3 (S3) | 1.69 | 1.73 | 1.71 | ||
| Support 4 (S4) | 1.70 |
